Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability
Jordi Bonaventura, Sherry Lam, Meghan L. Carlton, Matthew A. Boehm, Juan L. Gomez, Óscar Solís, Marta Sánchez‐Soto, Patrick J. Morris, Ida Fredriksson, Craig J. Thomas, David R. Sibley, Yavin Shaham, Carlos A. Zarate, Michael Michaelides
Topics & Concepts
KetamineAbuse liabilityPsychologyDrugs of abuseBehavioral medicineNeuroscienceMedicinePsychiatryDrugTreatment of Major DepressionTryptophan and brain disordersNeurotransmitter Receptor Influence on Behavior